PHGE BiomX

BULLISH Impact: 7/10 PRESS-RELEASE
Horizon months Filed Apr 10, 2026 Processed 2mo ago Wire GlobeNewswire
Press release: m_and_a
Latest settled — T+20d ⚠ clustered
PHGE ▼ -78.58% at T+20d
LONG call ✗ call lost -78.58% · α vs SPY -87.11% · entry $2.89 → $0.6190
Next anchor: T+60d in 27d
Currently $0.6815 · -76.42% from $2.89 entry
Entry anchored
Apr 9, 02:20 PM ET
via Databento tick
T+1d
-9.00%
call -9.00% · α -9.97%
$2.63
settled 8w ago
T+5d
-36.33%
call -36.33% · α -40.84%
$1.84
settled 8w ago
T+20d
-78.58%
call -78.58% · α -87.11%
$0.6190
settled 5w ago
T+60d
call — · α —
in 27d

Price Chart

Loading chart...

Executive Summary

BiomX (PHGE) has completed the acquisition of Zorronet, an AI-powered command-and-control software company, from Water.io, marking its strategic entry into the defense, security, and rescue sector. The deal enhances BiomX's capabilities in real-time threat detection and operational intelligence, leveraging Zorronet's existing contracts with the Israel Defense Forces and critical infrastructure entities.

Actionable Insight

Traders should monitor for future revenue synergies and integration progress with DFSL; the acquisition provides immediate access to mission-critical defense deployments, which could accelerate BiomX's commercialization in the sector despite its small market cap.

Key Facts

  • BiomX completed the acquisition of 100% of Zorronet from Water.io.
  • Zorronet develops AI-driven software that integrates video analytics, drones, sensors, and IoT devices into a unified threat detection and response platform.
  • The company has active contracts with the Israel Defense Forces, Israel Railways, Elbit Systems, and international government clients.
  • This acquisition positions BiomX in the growing $44B global command-and-control systems market by 2030.
  • Complements BiomX’s prior option to acquire DFSL, a LADAR/C-UAS technology firm, building a diversified defense and security portfolio.

Financial Impact

Deal value not disclosed, but strategic entry into a high-growth defense sector with existing revenue-generating contracts.

revenuestrategic positioningmarket expansion

Risk Factors

  • Undisclosed deal value raises concerns about potential dilution or balance sheet impact.
  • Execution risk in integrating Zorronet and scaling BiomX’s new defense business line.

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3271723
7 reports for PHGE
Performance horizon
0% Hit rate 0 of 3 directional calls best @ T+1▼ −9.00%Apr 10, 2026
Filters
Rows
Reports for PHGE — sortable, filterable
Type Now
May 28, 2026
12d ago
8-K
NEUTRAL ★ 2/10
$1.56 $0.8680▼ −44.36%▼ −44.31%$0.6815 (−56.31%)
Apr 30, 2026
5w ago
10-K/A
NEUTRAL ★ 3/10
$0.7900 $0.6270▼ −20.63%▼ −22.98%$0.6815 (−13.73%)
Apr 16, 2026
7w ago
8-K
NEUTRAL ★ 5/10
$1.84 $1.11▼ −39.67%▼ −40.23%$0.6815 (−62.96%)
Apr 13, 2026
8w ago
8-K
BULLISH ★ 7/10
$2.63 $1.46▼ −44.49%▼ −47.78%$0.6815 (−74.09%)
Apr 13, 2026
8w ago
Press Release
BULLISH ★ 7/10
$2.63 $1.46▼ −44.49%▼ −47.78%$0.6815 (−74.09%)
Apr 10, 2026
8w ago
8-K
BULLISH ★ 7/10
$2.89 $1.84▼ −36.33%▼ −40.84%$0.6815 (−76.42%)
Apr 10, 2026
8w ago
Press Release
BULLISH ★ 7/10
$2.89 $1.84▼ −36.33%▼ −40.84%$0.6815 (−76.42%)
Showing 7 of 7

US Market Status

Market Closed — Opens Thu (10h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access